These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2004-004031-59 Weekly maintainance therapy with Paclitaxel vs control arm after first line chemotherapy in patients with metastatic breast carcinoma. Phase III multicentric clinical trial. bad-data
Completed, but no date 2004-004339-78 FOLFOX6 TRIAL: TREATMENT OF THE FIRST LINE OF LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER. CLINICAL TRIAL ABOUT BIOMOLECULAR PREDICTIVE FACTORS bad-data
Not reported 2005-000194-21 Effetti della L-argina nella profilassi della ipertensione cronica dal secondo trimestre di gravidanza 2010-05-04 due-trials
Completed, but no date 2005-000722-24 PHASE II STUDY WITH CETUXIMAB SINGLE AGENT FOLLOWED BY 5-FU, CETUXIMAB AND PELVIC RADIOTHERAPY AS NEO-ADJUVANT TREATMENT FOR OPERABLE, LOCALLY ADVANCED RECTAL CANCER bad-data
Completed, but no date Terminated 2005-002269-35 Phase II trial to evaluate the combination of FOLFOX6 + Bevacizumab in initially unresectable liver metastases from colorectal cancer bad-data
Completed, but no date Terminated 2005-003403-36 Trattamento con Capecitabina e Gemcitabina in pazienti con carcinoma della mammella metastatico pretrattati con Taxani ed Antracicline. Studio di fase II. bad-data
Completed, but no date Terminated 2005-003582-16 Dose-dense treatment with gemcitabine, epirubicin and paclitaxel GET combination in advanced breast cancer a phase II parallel study bad-data
Completed, but no date Terminated 2005-004927-20 Trial randomizzato: progetto di telemonitoraggio di pazienti affetti da grave broncopneumopatia cronica ostruttiva in ossigenoterapia domiciliare a lungo termine confrontato con il protocollo di contr... bad-data
Completed, but no date 2005-004936-34 Il therapeutic drug monitoring di Atazanavir in pazienti con infezione da HIV e malattia epatica terminale valutati per trapianto ortotopico di fegato bad-data
Completed, but no date 2006-001014-32 PHASE II STUDY OF BAY 43-9006 IN PATIENTS WITH ADVANCED CHOLANGIOCELLULAR CARCINOMA bad-data
Completed, but no date 2006-001238-41 Phase II trial of Erlotinib in combination with increasing dose of gemcitabine given as fixed dose rate infusion in advanced pancreatic cancer. bad-data
Completed, but no date Terminated 2006-002179-41 Studio aperto, randomizzato, controllato per valutare gli effetti di nuove soluzioni biocompatibili per Dialisi Peritoneale(poliglucosio, aminoacidi, bicarbonato/lattato)rispetto alle soluzioni standa... bad-data
Ongoing 2006-005354-68 Confronto tra un regime terapeutico basato sui livelli sierici di procalcitonina rispetto ad un regime terapeutico standard in pazienti ospedalizzati per riacutizzazione di broncopneumopatia cronica o... not-yet-due
Completed, but no date 2007-000526-48 Randomized, monocentric trial on sintoms, adherence,toxicity of alternate antiretrovirale regimen bad-data
Ongoing 2007-003672-19 NON APPLICABILE not-yet-due
Ongoing 2007-004326-25 SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE not-yet-due
Completed, but no date 2007-005221-29 Curve di Wash-in/wash-out e tempi di recupero dopo anestesia con Sevoflurane vs. Desflurane in pazienti affetti da obesita' patologica bad-data
Not reported 2007-007873-22 Uso del Nabilone nel trattamento del dolore cronico in pazienti con MOH non rispondenti ad altri trattamenti 2011-03-01 due-trials
Ongoing 2007-007890-22 Prevention of portal vein Thrombosis with anticoagulant therapy in patients with hepatic cirrhosis (Child B and C) not-yet-due
Ongoing 2007-007907-34 Conversione della terapia immunosoppressiva a Sirolimus (Rapamune) monoterapia per complicanze da inibitori della calcineurina, in pazienti sottoposti a trapianto ortotopico di fegato. not-yet-due
Not reported 2007-007927-42 Nessuna correzione vs nuova formula per l’impostazione delle caratteristiche antropometriche per Target Controlled Infusion (TCI) di remifentanil in pazienti obesi. 2008-12-31 due-trials
Completed, but no date 2007-007931-25 Prospective evaluation on the role exerted by the association of ethinylestradiol (0,03 mg) plus clormadinone acetate (2 mg) or ethinylestradiol (0,02 mg) plus desogestrel (0,15 mg) on insulin sensiti... bad-data
Ongoing 2008-001260-36 Terapia PEG-Interferone alfa 2B+Ribavirina versus terapia PEG-Interferone alfa 2B + Ribavirina+ Terapia ormonale sostitutiva (TOS) nella prevenzione della progressione della fibrosi epatica nell’epati... not-yet-due
Completed, but no date 2008-005891-28 Perspective evaluation on the role practiced by three different contraceptive hormonal on l I risk cardiovascular in young women: impact on the sensibility' insulinica bad-data
Ongoing 2008-006217-25 Utilizzo intraoperatorio del verde indocianina-pulsion quale test predittivo di insufficienza epatica dopo resezione epatica maggiore not-yet-due
Completed, but no date Terminated 2008-007989-34 Use of policlonal immunoglobulins (Pentaglobin) in the treatment of sepsis in cirrhotic patients awaiting for liver transplantation. bad-data
Completed, but no date 2009-009367-64 PREEMPTIVE ANALGESIA DURING A SPRING FINGER INTERVENTION UNDER LOCAL ANAESTHESIA bad-data
Completed, but no date Terminated 2009-010640-34 INDUCTION OF DONOR-SPECIFIC TOLERANCE IN PATIENTS WITH LIVER TRANSPLANTATION WITH RECIPIENT PRE-TREATMENT WITH THYMOGLOBULINE AND MINIMAL POST-TRANSPLANT IMMUNOSUPPRESSION. bad-data
Completed, but no date Terminated 2009-010804-27 ROLE OF NITRIC OXIDE IN LUNG INFLAMMATION OF COPD PATIENTS bad-data
Not reported Terminated 2009-011225-14 A PROSPECTIVE, MULTICENTER PHASE II STUDY EVALUATING PREDICTIVE FACTORS FOR LENALIDOMIDE TREATMENT RESPONSE IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. 2012-07-16 due-trials
Ongoing 2009-012344-17 A randomized, open label, single center, phase IIa controlled trial to assess tolerability, safety and effect of treatment with deferasirox plus standard antiviral therapy versus standard antiviral t... not-yet-due
Other 2009-013498-17 IntraCoronary Abciximab with the ClearWay Catheter To Improve Outcomes with Lysis (IC ClearLy) Trial not-yet-due
Not reported 2010-020240-35 Significance of the FSH receptor polymorphism p.N680S for the efficacy of FSH therapy of idiopathic male infertility: a pharmacogenetic approach. 2015-04-14 due-trials
Completed, but no date Terminated 2010-021090-36 LAPATINIB plus LETROZOLE or CAPECITABINE AS FIRST LINE TREATMENT OF ER+/HER2+ METASTIC BREAST CANCER– A phase IIb randomized study with built-in crossover bad-data
Completed, but no date 2010-022077-33 Phase II, open label, study of primary chemotherapy with Bevacizumab in association with carboplatin, paclitaxel in early and locally advanced triple negative (ER, PgR and HER2 negative) breast cance... bad-data
Ongoing 2011-002459-33 Boceprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Difficult-to-Treat Menopausal Women With Chronic Hepatitis C Genotype 1, either deemed Nonresponders to Peginterferon/Ribavirin or... not-yet-due
Ongoing 2011-005973-21 A prospective, randomized, open-label trial of two abacavir/lamivudine based regimen (ABC/3TC + darunavir/ritonavir or ABC/3TC + raltegravir) in late presenter naïve patients (with CD4 count <200 cell... not-yet-due
Completed, but no date 2012-000955-15 A phase IIa open-label, single arm, multi-center trial evaluating the safety of standard antiviral therapy (pegylated interferon and ribavirin) plus deferasirox in thalassemia patients with transfusio... bad-data
Ongoing 2012-002012-46 A pilot phase II study to assess the efficacy of Brentuximab Vedotin administered sequentally with ABVD chemotherapy in patients with untreated Hodgkin Lymphoma Studio pilota di fase II per valutar... not-yet-due
Ongoing 2016-000823-24 P-HIPEC CYTOREDUCTION PLUS HIPEC IN PATIENTS AFFECTED BY PERITONEAL CARCINOMATOSIS: A FEASIBILITY TRIAL P-HIPEC Fattibilit¿ della cito-riduzione associata ad HIPEC nei pazienti con carcinosi per... not-yet-due
Ongoing 2016-001314-25 A phase II study of Pembrolizumab plus Carboplatin in BRCA-related metastatic breast cancer Studio di Fase II della combinazione di Pembrolizumab e Carboplatino nelle pazienti con tumore della mamm... not-yet-due
Completed, but no date 2016-002399-28 Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis bad-data
Ongoing 2017-003621-15 A Phase II study of a Combination of Eribulin and capecitabiNe in second line Treatment after the failure of gemcitabine/abraxane first line in advanced pancreatic cancer Studio di Fase II di eribu... not-yet-due
Ongoing 2017-004459-21 Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial Trattamento con colchicina per la Sclerosi Laterale Amiotrofica: u... not-yet-due
Ongoing 2018-001613-33 Efficacy and safety of adjunctive IgM-enriched immunoglobulin therapy with a personalized dose based on serum IgM-titers vs. standard dose in patients with septic shock. A multicenter, interventional,... not-yet-due
Ongoing 2018-002525-35 Conservative vs conventional oxygen administration in critically ill patients: effects on ICU mortality. A multicentre randomized open label clinical trial. Somministrazione di ossigeno conservativ... not-yet-due
Ongoing 2019-004685-18 Evaluation of diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT in primary staging of Intermediate and High Risk Prostatic Cancer in men newly diagnosed Valutazione della accuratezza diagnostica della... not-yet-due
Exempt 2020-000836-23 Continous fentanyl infusion in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia: pharmacokinetics study Fentanile in infusione continua in neonati con encefalopati... not-yet-due
Exempt 2020-001577-70 Allogeneic Mesenchymal Stromal Cell (MSC) Therapy for SARS-CoV-2 Pneumonia: A Prospective Randomized Multicentre Phase I/IIa Open Label Study Studio prospettico randomizzato multicentrico di fase I... not-yet-due
Ongoing 2020-001921-30 Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design. Steroidi e eparina non fra... not-yet-due
Ongoing 2020-001972-13 Randomised controlled trial comparing efficacy and safety of high versus low low-molecular weight heparin dosages in hospitalised patients with severe COVID-19 pneumonia and coagulopathy not requiring... not-yet-due
Ongoing 2020-005291-35 A multicenter randomized trial to evaluate the efficacy of tocilizumab in patients with severe Coronavirus Disease 2019 (Covid-19) pneumonia failing glucocorticoids. Studio multicentrico randomizza... not-yet-due